Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeystone Positive Change Investment Trust Regulatory News (KPC)

  • This share is currently suspended. It was suspended at a price of 223.00
  • There is currently no data for KPC

ISS Voting Recommendations

24 Jan 2025 07:00

RNS Number : 5185U
Keystone Positive Change I.T. PLC
24 January 2025
 

Keystone Positive Change Investment Trust plc (KPC)

 

ISS recommends shareholders vote "AGAINST" the Saba Resolutions

 

Keystone Positive Change Investment Trust plc ("KPC" or "the Company") notes the publication of the voting recommendation from ISS, the independent proxy advisor, in relation to the Company's general meeting to be held on 3 February 2025 at 12 noon (the "General Meeting").

 

ISS recommends that KPC shareholders vote "AGAINST" all the proposed Requisitioned Resolutions at the General Meeting on 3 February 2025.

 

ISS states that Saba Capital has not presented a compelling case for change, let alone a case for a majority position on the Board and a strategy overhaul. ISS also states that it does not appear that Saba's proposals will yield a superior alternative for shareholders than the full cash exit or tax-efficient rollover option already proposed by KPC.

 

This follows the recommendation from Glass Lewis, the independent proxy advisor, who also recommended shareholders VOTE AGAINST the Requisitioned Resolutions.

 

The recommendation is consistent with the unanimous recommendation of the KPC independent board of directors.

 

Karen Brade, Chair of Keystone Positive Change, said:

 

"ISS has joined Glass Lewis and the Board in recommending that shareholders VOTE AGAINST all of Saba's resolutions. No one is fooled by Saba's plot for control.

 

"We are pleased that ISS supports the view that the Saba proposals do not offer a better alternative to KPC shareholders than the full cash exit or tax-efficient rollover option that has already been proposed by the independent board. Now shareholders must come out and vote. Only a massive turnout of Keystone shareholders voting AGAINST will allow us to implement this plan and stop Saba seizing control of the Company."

 

YOUR VOTE IS VERY IMPORTANT. The Requisitioned Resolutions are each being proposed as ordinary resolutions. This means that they only require more than 50 per cent of the votes cast to be voted in favour in order to pass. Saba has declared interests in approximately 28 per cent. of the Company's issued Ordinary Share capital. Therefore, the Board believes that other shareholders representing at least 30 per cent. of the Company's issued Ordinary Share capital are required to VOTE AGAINST the Requisitioned Resolutions in order to ensure they are blocked. FAILURE TO TAKE ACTION MAY LEAD TO SABA TAKING CONTROL OF YOUR COMPANY.

 

How to vote

 

The General Meeting to vote on the Requisitioned Resolutions will be held at the offices of Deutsche Numis, 45 Gresham Street, London EC2V 7BF on 3 February 2025 at 12 noon.

 

Investors who hold their Ordinary Shares through an investment platform provider or nominee are encouraged to contact their investment platform provider or nominee as soon as possible to arrange for VOTES AGAINST each of the Requisitioned Resolutions to be lodged on their behalf. Further information on how to vote through platforms can be found at the following link: https://www.theaic.co.uk/how-to-vote-your-shares

 

If shareholders have any questions as to how they can arrange for their investment platform provider or nominee to VOTE AGAINST each of the Requisitioned Resolutions or would like guidance on this process, they should email the Company's proxy solicitation agent at keystone@georgeson.com.

 

For further information please contact:

 

Deutsche Numis (Financial Advisor and Corporate Broker)

Nathan Brown

Tel: 020 7260 1426

 

Baillie Gifford & Co (Investment Manager)

Naomi Cherry

Tel 0131 275 2000

 

Greenbrook Advisory (PR Advisor)

Rob White, Peter Hewer and Ksenia Galouchko

Tel: 020 7952 2000

Email: KeystonePositiveChange@greenbrookadvisory.com

 

 

Important information

 

Capitalised terms used throughout this announcement shall have the meanings ascribed to them in the circular published by the Company on 6 January 2025, unless the context otherwise requires.

 

Neither the content of the websites referred to in this announcement, nor the content of any other website accessible from hyperlinks on such websites, is incorporated into, or forms part of, this announcement.

 

Legal Entity Identifier: 5493002H3JXLXLIGC563

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

 

 

Baillie Gifford & Co Limited

Company Secretaries

24 January 2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBRGDBBGDDGUX
Date   Source Headline
24th Jan 20257:00 amRNSISS Voting Recommendations
23rd Jan 20254:50 pmRNSTransaction in Own Shares
23rd Jan 202511:53 amRNSNet Asset Value(s)
22nd Jan 20254:58 pmRNSTransaction in Own Shares
22nd Jan 202512:09 pmRNSNet Asset Value(s)
21st Jan 202511:19 amRNSNet Asset Value(s)
21st Jan 20257:00 amRNSDoc Re: Glass Lewis Voting Recommendation
20th Jan 202511:04 amRNSNet Asset Value(s)
17th Jan 202511:49 amRNSNet Asset Value(s)
16th Jan 202512:21 pmRNSNet Asset Value(s)
15th Jan 202512:00 pmRNSNet Asset Value(s)
14th Jan 202512:48 pmRNSDirector/PDMR Shareholding
14th Jan 202512:03 pmRNSNet Asset Value(s)
13th Jan 202512:47 pmRNSNet Asset Value(s)
13th Jan 20257:00 amRNSScheme General Meeting Update
10th Jan 202511:53 amRNSNet Asset Value(s)
9th Jan 202512:18 pmRNSNet Asset Value(s)
8th Jan 20255:18 pmRNSHolding(s) in Company
8th Jan 20253:50 pmRNSHolding(s) in Company
8th Jan 202511:42 amRNSNet Asset Value(s)
7th Jan 20256:16 pmRNSHolding(s) in Company
7th Jan 202511:46 amRNSNet Asset Value(s)
6th Jan 202511:34 amRNSNet Asset Value(s)
6th Jan 20257:00 amRNSCircular & Notice of Requisitioned General Meeting
3rd Jan 202511:23 amRNSNet Asset Value(s)
2nd Jan 20251:40 pmRNSNet Asset Value(s)
2nd Jan 202512:34 pmRNSNet Asset Value(s)
31st Dec 202411:17 amRNSNet Asset Value(s)
30th Dec 202412:03 pmRNSNet Asset Value(s)
27th Dec 20241:07 pmRNSNet Asset Value(s)
27th Dec 202412:16 pmRNSNet Asset Value(s)
27th Dec 202411:23 amRNSNet Asset Value(s)
24th Dec 202411:20 amRNSNet Asset Value(s)
24th Dec 20249:50 amRNSHolding(s) in Company
23rd Dec 202412:14 pmRNSHolding(s) in Company
23rd Dec 202411:49 amRNSNet Asset Value(s)
23rd Dec 20247:00 amRNSRepayment of Preference Shares
20th Dec 20244:18 pmRNSHolding(s) in Company
20th Dec 20244:14 pmRNSHolding(s) in Company
20th Dec 202412:42 pmRNSNet Asset Value(s)
20th Dec 202410:00 amRNSHolding(s) in Company
20th Dec 20249:58 amRNSHolding(s) in Company
19th Dec 202411:55 amRNSNet Asset Value(s)
18th Dec 20245:49 pmRNSResponse to Requisition of a General Meeting
18th Dec 202412:24 pmRNSNet Asset Value(s)
17th Dec 202412:19 pmRNSNet Asset Value(s)
17th Dec 20249:41 amRNSHolding(s) in Company
16th Dec 20244:19 pmRNSHolding(s) in Company
16th Dec 202412:40 pmRNSNet Asset Value(s)
13th Dec 202412:44 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.